(Q34420689)

2 August 2017

1 reference

title

Antidepressants in the treatment of neuropathic pain (English)

1 reference

2 August 2017

Antidepressants in the Treatment of Neuropathic Pain (English)

0 references

0 references

Søren H Sindrup

1

0 references

Troels Staehelin Jensen

4

object named as

Troels S Jensen

1 reference

2 August 2017

Marit Otto

2

1 reference

2 August 2017

Nanna B Finnerup

3

1 reference

2 August 2017

Soren H. Sindrup

1

0 references

Nanna B. Finnerup

3

0 references

Troels S. Jensen

4

0 references

publication date

1 June 2005

1 reference

Basic and Clinical Pharmacology and Toxicology

2 August 2017

June 2005

0 references

published in

1 reference

2 August 2017

96

1 reference

2 August 2017

399-409

1 reference

2 August 2017

6

1 reference

Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research

2 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

Predicting the impact of physiological and biochemical processes on oral drug bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

In silico prediction of ADME and pharmacokinetics. Report of an expert meeting organised by COST B15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

BOOMER, a simulation and modeling program for pharmacokinetic and pharmacodynamic data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

Application of neural networks to population pharmacokinetic data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

CXT: a programme for analysis of linear dynamic systems in the frequency domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

A model for transport and dispersion in the circulatory system based on the vascular fractal tree.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

The heterogeneous course of drug transit through the body.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

Non-congeneric structure-pharmacokinetic property correlation studies using fuzzy adaptive least-squares: oral bioavailability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

A physiologically based approach for the estimation of recirculatory parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

Gastrointestinal drug absorption: is it time to consider heterogeneity as well as homogeneity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

Obtaining interpretable fuzzy classification rules from medical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

Fuzzy modeling of skin permeability coefficients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

Prediction of oral bioavailability by adaptive fuzzy partitioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

Fuzzy pharmacology: theory and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

Fuzzy logic pharmacokinetic modeling: application to lithium concentration prediction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

Application of artificial neural networks in the design of controlled release drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

ADMET in silico modelling: towards prediction paradise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

Application of artificial neural network modelling to identify severely ill patients whose aminoglycoside concentrations are likely to fall below therapeutic concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

Clinical application of artificial neural network (ANN) modeling to predict pharmacokinetic parameters of severely ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_01.X

Incidence of central post-stroke pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

The number needed to treat: a clinically useful measure of treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Inhibition of synaptosomal veratridine-induced sodium influx by antidepressants and neuroleptics used in chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Amitriptyline inhibits striatal efflux of neurotransmitters via blockade of voltage-dependent Na+ channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

The clinical picture of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Central post-stroke pain--a controlled trial of amitriptyline and carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Amitriptyline, but not lorazepam, relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

TDM-based imipramine treatment in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Cyclic antidepressants and the risk of hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Cyclic antidepressants and the risk of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Antidepressants inhibit spontaneous oscillations of intracellular Ca2+ concentration in rat cortical cultured neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

St. John's wort has no effect on pain in polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Venlafaxine in neuropathic pain following treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Lamotrigine for central poststroke pain: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

State-dependent block of voltage-gated Na+ channels by amitriptyline via the local anesthetic receptor and its implication for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Tricyclic antidepressants block NMDA receptor-mediated synaptic responses and induction of long-term potentiation in rat hippocampal slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Amitriptyline versus placebo in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

Neuropathic pain: aetiology, symptoms, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO_96696601.X

10.1111/J.1742-7843.2005.PTO_01.X

21 January 2018

Identifiers

DOI

1 reference

10.1111/J.1742-7843.2005.PTO_96696601.X

2 August 2017

0 references

1 reference